UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 263

Sortiert nach

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)

Diabetes care, 2014-08, Vol.37 (8), p.2149-2158

2014

Volltextzugriff (PDF)

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)

Cardiovascular diabetology, 2023-04, Vol.22 (1), p.79-79, Article 79

2023

Volltextzugriff (PDF)

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial

Diabetes care, 2016-08, Vol.39 (8), p.1318-1328

2016

Volltextzugriff (PDF)

Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials

Cardiovascular diabetology, 2020-05, Vol.19 (1), p.1-10

2020

Volltextzugriff (PDF)

Prognostic indicators in pituitary adenoma surgery: a comprehensive analysis of surgical outcomes and complications

Frontiers in endocrinology (Lausanne), 2024-01, Vol.14, p.1327404-1327404

2024

Volltextzugriff (PDF)

Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial

The lancet. Diabetes & endocrinology, 2014-06, Vol.2 (6), p.464-473

2014

Volltextzugriff (PDF)

Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial

The Lancet (British edition), 2012-06, Vol.379 (9833), p.2270-2278

2012

Volltextzugriff (PDF)

Tirzépatide : les leçons du programme clinique SURPASS. Au-delà de l’équilibre glycémique

Médecine des maladies métaboliques, 2023-09, Vol.17 (5), p.418-423

Guerci, Bruno

2023

Volltextzugriff (PDF)

Quelle place de la diabétologie connectée pour les patients en multi-injections d'insuline ?

Médecine des maladies métaboliques, 2023-03, Vol.17 (2), p.2S11-2S21

Guerci, Bruno

2023

Volltextzugriff (PDF)

Reply

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.801

2020

Volltextzugriff (PDF)

High glycemic variability assessed by continuous glucose monitoring after surgical treatment of obesity by gastric bypass

Diabetes technology & therapeutics, 2011-06, Vol.13 (6), p.625

2011

Volltextzugriff (PDF)

Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs

Diabetes care, 2003-03, Vol.26 (3), p.582-589

2003

Volltextzugriff (PDF)

Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis

Endocrinology, diabetes & metabolism, 2019-07, Vol.2 (3), p.e00061-n/a

2019

Volltextzugriff (PDF)

Accuracy of an Electrochemical Sensor for Measuring Capillary Blood Ketones by Fingerstick Samples During Metabolic Deterioration After Continuous Subcutaneous Insulin Infusion Interruption in Type 1 Diabetic Patients

Diabetes care, 2003-04, Vol.26 (4), p.1137-1141

2003

Volltextzugriff (PDF)

Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials : Perspective on GLP-1 RA and SGLT-2i therapies

Cardiovascular diabetology, 2020-05, Vol.19 (1), p.65-65, Article 65

2020

Volltextzugriff (PDF)

Pragmatic Diabetes Management in Nursing Homes: Individual Care Plan

Journal of the American Medical Directors Association, 2013-11, Vol.14 (11), p.791-800

2013

Volltextzugriff (PDF)

Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study

Diabetes care, 2021-06, Vol.44 (6), p.1368-1376

2021

Volltextzugriff (PDF)

Reply

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.801-801

2020

Volltextzugriff (PDF)

Reply

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.801

2020

Volltextzugriff (PDF)

The Benefits of Metformin Therapy During Continuous Subcutaneous Insulin Infusion Treatment of Type 1 Diabetic Patients

Diabetes care, 2002-12, Vol.25 (12), p.2153-2158

2002

Volltextzugriff (PDF)

Tirzépatide : les leçons du programme clinique SURPASS

Médecine des maladies métaboliques, 2023-09, Vol.17 (5), p.410-417

2023

Volltextzugriff (PDF)

The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study

Diabetes therapy, 2021-08, Vol.12 (8), p.2207-2221

2021

Volltextzugriff (PDF)

Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France

Diabetes technology & therapeutics, 2023-01, Vol.25 (1), p.20

2023

Volltextzugriff (PDF)

Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: The RealTrend study

Diabetes care, 2009-12, Vol.32 (12), p.2245-2250

2009

Volltextzugriff (PDF)

1 – 25 von 263

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(235)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial

Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials

Prognostic indicators in pituitary adenoma surgery: a comprehensive analysis of surgical outcomes and complications

Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial

Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial

Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial

Tirzépatide : les leçons du programme clinique SURPASS. Au-delà de l’équilibre glycémique

Quelle place de la diabétologie connectée pour les patients en multi-injections d'insuline ?

Reply

High glycemic variability assessed by continuous glucose monitoring after surgical treatment of obesity by gastric bypass

Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs

Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis

Accuracy of an Electrochemical Sensor for Measuring Capillary Blood Ketones by Fingerstick Samples During Metabolic Deterioration After Continuous Subcutaneous Insulin Infusion Interruption in Type 1 Diabetic Patients

Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials : Perspective on GLP-1 RA and SGLT-2i therapies

Pragmatic Diabetes Management in Nursing Homes: Individual Care Plan

Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study

Reply

Reply

The Benefits of Metformin Therapy During Continuous Subcutaneous Insulin Infusion Treatment of Type 1 Diabetic Patients

Tirzépatide : les leçons du programme clinique SURPASS

The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study

Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France

Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: The RealTrend study

Suchergebnisse filtern